Kevin Jones, M.D.

Department of Orthopaedics, University of Utah
Salt lake city, Utah, United States

Disclosure information not submitted.

Presentation(s):

• Paper 34 - FUSION ONCOPROTEIN SS18::SSX MODULATES BAF CHROMATIN REMODELING TO REPROGRAM TRANSCRIPTION

  Thursday, November 14, 2024
  4:45 PM – 5:45 PM PST

• Paper 57 - DNA DEMETHYLATING AGENTS REPRESENT A THERAPEUTIC OPPORTUNITY FOR SYNOVIAL SARCOMA

  Friday, November 15, 2024
  2:00 PM – 3:00 PM PST

• Paper 62 - EVALUATING EPIGENETICS AND THERAPEUTIC METABOLIC TARGETS OF THE EWSR1::ATF1 FUSION GENE IN CLEAR CELL SARCOMA

  Friday, November 15, 2024
  2:00 PM – 3:00 PM PST